CliniSciences: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
CliniSciences
Largest movements
- Cash +€162,632
up €162,632 (+128%), from €126,876 to €289,508
mainly Trade debts (+€164,781) and Net result for the year (+€74,409)
- Receivables within one year -€33,389
down €33,389 (-34.0%), from €98,273 to €64,884
- Trade debts +€164,781
up €164,781 (+605%), from €27,259 to €192,040
- Reserves -€28,850
no longer reported in 2025 (was €28,850)
- Tax, wage and social debts -€21,078
down €21,078 (-29.4%), from €71,614 to €50,536
of which Taxes: -€27,497
- Other debts +€14,390
up €14,390 (+16.5%), from €87,426 to €101,816
- Staff costs +€16,643
up €16,643 (+15.7%), from €105,896 to €122,539
- Taxes -€6,941
down €6,941 (-21.7%), from €32,017 to €25,076
- Gross operating margin -€5,512
down €5,512 (-2.4%), from €228,133 to €222,621
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €225,149 | €354,392 | +€129,243 | +57.4% |
| Current assets | 29/58 | €225,149 | €354,392 | +€129,243 | +57.4% |
| Amounts receivable within one year | 40/41 | €98,273 | €64,884 | -€33,389 | -34.0% |
| Trade receivables | 40 | €98,273 | €64,884 | -€33,389 | -34.0% |
| Cash at bank and in hand | 54/58 | €126,876 | €289,508 | +€162,632 | +128% |
| Total equity and liabilities | 10/49 | €225,149 | €354,392 | +€129,243 | +57.4% |
| Equity | 10/15 | €38,850 | €10,000 | -€28,850 | -74.3% |
| Contributions | 10/11 | €10,000 | €10,000 | = | 0.0% |
| Reserves | 13 | €28,850 | - | -€28,850 | |
| Distributable reserves | 133 | €28,850 | - | -€28,850 | |
| Amounts payable | 17/49 | €186,299 | €344,392 | +€158,093 | +84.9% |
| Amounts payable within one year | 42/48 | €186,299 | €344,392 | +€158,093 | +84.9% |
| Trade debts | 44 | €27,259 | €192,040 | +€164,781 | +605% |
| Suppliers | 440/4 | €27,259 | €192,040 | +€164,781 | +605% |
| Taxes, remuneration and social security | 45 | €71,614 | €50,536 | -€21,078 | -29.4% |
| Taxes | 450/3 | €57,947 | €30,450 | -€27,497 | -47.5% |
| Remuneration and social security | 454/9 | €13,667 | €20,086 | +€6,419 | +47.0% |
| Other amounts payable | 47/48 | €87,426 | €101,816 | +€14,390 | +16.5% |
| Remuneration, social security and pensions | 62 | €105,896 | €122,539 | +€16,643 | +15.7% |
| Other operating charges | 640/8 | €387 | €400 | +€13 | +3.4% |
| Gross operating margin | 9900 | €228,133 | €222,621 | -€5,512 | -2.4% |
| Operating profit (loss) | 9901 | €121,850 | €99,682 | -€22,168 | -18.2% |
| Financial charges | 65/66B | €2,407 | €197 | -€2,210 | -91.8% |
| Recurring financial charges | 65 | €2,407 | €197 | -€2,210 | -91.8% |
| Profit (loss) for the period before taxes | 9903 | €119,443 | €99,485 | -€19,958 | -16.7% |
| Income taxes | 67/77 | €32,017 | €25,076 | -€6,941 | -21.7% |
| Profit (loss) for the period | 9904 | €87,426 | €74,409 | -€13,017 | -14.9% |
| Profit (loss) for the period to be appropriated | 9905 | €87,426 | €74,409 | -€13,017 | -14.9% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 17 October 2026 via checked.be.